Treatment of penicillin-resistant staphylococcal infections with clindamycin. 1971

R D Feigin, and P Shackelford, and R E Keeney, and J N Middelkamp

UI MeSH Term Description Entries
D007169 Impetigo A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose. Impetigo Contagiosa,Contagiosa, Impetigo,Contagiosas, Impetigo,Impetigo Contagiosas,Impetigos
D007223 Infant A child between 1 and 23 months of age. Infants
D008034 Lincomycin An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. Lincolnensin,Lincomycin, (2S-cis)-Isomer,Epilincomycin,Lincocin,Lincomycin A,Lincomycin Hydrochloride,Lincomycin Monohydrochloride,Lincomycin Monohydrochloride, (2S-cis)-Isomer,Lincomycin Monohydrochloride, (L-threo)-Isomer,Lincomycin Monohydrochloride, Hemihydrate,Lincomycin, (L-threo)-Isomer,Hemihydrate Lincomycin Monohydrochloride
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D011023 Pneumonia, Staphylococcal Pneumonia caused by infections with bacteria of the genus STAPHYLOCOCCUS, usually with STAPHYLOCOCCUS AUREUS. Staphylococcal Pneumonia,Staphylococcus Aureus Pneumonia,Pneumonia, Staphylococcus Aureus,Pneumonias, Staphylococcal,Pneumonias, Staphylococcus Aureus,Staphylococcal Pneumonias,Staphylococcus Aureus Pneumonias
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

R D Feigin, and P Shackelford, and R E Keeney, and J N Middelkamp
June 1966, The Medical letter on drugs and therapeutics,
R D Feigin, and P Shackelford, and R E Keeney, and J N Middelkamp
July 1958, Nordisk medicin,
R D Feigin, and P Shackelford, and R E Keeney, and J N Middelkamp
July 1958, Nordisk medicin,
R D Feigin, and P Shackelford, and R E Keeney, and J N Middelkamp
June 1954, Minerva medica,
R D Feigin, and P Shackelford, and R E Keeney, and J N Middelkamp
February 1968, Archives of disease in childhood,
R D Feigin, and P Shackelford, and R E Keeney, and J N Middelkamp
July 1958, Nordisk medicin,
R D Feigin, and P Shackelford, and R E Keeney, and J N Middelkamp
July 1957, British medical journal,
R D Feigin, and P Shackelford, and R E Keeney, and J N Middelkamp
May 1956, Lancet (London, England),
R D Feigin, and P Shackelford, and R E Keeney, and J N Middelkamp
July 1958, Nordisk medicin,
R D Feigin, and P Shackelford, and R E Keeney, and J N Middelkamp
November 1955, Der Tuberkulosearzt,
Copied contents to your clipboard!